Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 10/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LAP3 | P28838 | 3/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.45 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.45 |
| ▸ | GRN | P28799 | 1/20 | 0.42 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27337953 | 0.84 | FOLH1 (0.64) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL23964665 | 0.84 | FOLH1 (0.64) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL628966 | 0.80 | ALDH1A1 (0.64) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL628967 | 0.80 | ALDH1A1 (0.64) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL3447885 | 0.80 | ALDH1A1 (0.64) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL729840 | 0.79 | ALDH1A1 (0.58) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL9830039 | 0.79 | ALDH1A1 (0.58) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL9557207 | 0.79 | ALDH1A1 (0.58) | FOLH1ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL28951727 | 0.79 | MME (0.63) | FOLH1 | |
| SCHEMBL25525724 | 0.79 | MME (0.63) | FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332193-A1 | AMINO ACID-MODIFIED POLYMER FOR ADHESION PREVENTION AND APPLICATION THEREOF | PRO-VIEW BIOTECH CO., LTD. (TW) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332193-A1 | AMINO ACID-MODIFIED POLYMER FOR ADHESION PREVENTION AND APPLICATION THEREOF | PTK2, DNPEP, ARGLU1 | FOLH1 368/4885ALDH1A1 2834/4885MEN1 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.